Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Purine and Pyrrolopyrimidine-Based Small Molecules as Multitarget Therapeutics.

Archiv der Pharmazie·2026
Same author

Structure-guided identification of small molecules potentially able to modulate GDF15 activity.

Scientific reports·2026
Same author

Design, synthesis and biological activity of glycoconjugated ADAMTS5 exosite inhibitors: applications in osteoarthritis and ovarian cancer models.

Scientific reports·2025
Same author

On The Retrograde Transport of RNA-Loaded Lipid Nanoparticles Designed for Brain Delivery.

ACS nanoscience Au·2025
Same author

Improving Machine Learning Classification Predictions through SHAP and Features Analysis Interpretation.

Journal of chemical information and modeling·2025
Same author

Design, synthesis, and biological evaluation of chalcone derivatives as selective Monoamine Oxidase-B inhibitors with potential neuroprotective effects.

European journal of medicinal chemistry·2025

Related Experiment Video

Updated: Jun 6, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

BEAR, a novel virtual screening methodology for drug discovery.

Gianluca Degliesposti1, Corinne Portioli, Marco Daniele Parenti

  • 1Dipartimento di Scienze Farmaceutiche, Università di Modena e Reggio Emilia, Modena, Italy.

Journal of Biomolecular Screening
|November 19, 2010
PubMed
Summary

Binding Estimation After Refinement (BEAR) is a novel virtual screening technology that refines docking poses using molecular dynamics. This method significantly outperforms standard docking in identifying known inhibitors from large compound databases for drug discovery.

More Related Videos

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
09:03

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Related Experiment Videos

Last Updated: Jun 6, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
09:03

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Molecular modeling

Background:

  • Virtual screening is crucial for identifying drug candidates.
  • Standard docking methods have limitations in accuracy and efficiency.
  • Accurate prediction of binding free energies is essential for drug discovery.

Purpose of the Study:

  • To benchmark the performance of BEAR (Binding Estimation After Refinement) technology.
  • To evaluate BEAR's effectiveness in identifying known inhibitors from large compound databases.
  • To compare BEAR against standard docking screening methods.

Main Methods:

  • BEAR utilizes conformational refinement of docking poses via molecular dynamics.
  • Binding free energies are predicted using accurate scoring functions.
  • An extensive benchmark was performed on a 1.5 million compound database.

Main Results:

  • BEAR demonstrated significantly superior performance compared to standard docking methods.
  • The technology successfully identified a smaller subset of known inhibitors.
  • BEAR proved to be a reliable tool for virtual screening in drug discovery.

Conclusions:

  • BEAR is a fast, modular, and automated virtual screening technology.
  • It offers improved accuracy and efficiency over traditional docking approaches.
  • BEAR is applicable to any biological target with a known structure and any compound database.